Company profile

DexTech Medical AB

DEX · Spotlight Stock Market (Verified via web search: a Swedish drug-development company (urological oncology) listed on the Spotlight Stock Market (Stockholm) under ticker DEXTECH, not Nasdaq First North as initially assumed -- corrected after direct verification. Sources: https://clinicaltrials.gov/study/NCT06616389 Entity resolved by asset-pipeline-v2.)

Public Market Listing

DEXSpotlight Stock Market

Spotlight Stock Market primary exchange listing

Live quotes, historical charts, and market capitalization for DexTech Medical AB are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)

1Total Assets

0Approved

0Phase 3 / Filed

1Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
ODX (Osteodex)	Phase 2	Bone mineral (hydroxyapatite) / osteoclasts	Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.